Progressive Multifocal Leukoencephalopathy with Balanced CD4/CD8 T-Cell Infiltration and Good Response to Mefloquine

Nobuo Sanjo1, Satoko Kina, Yukiko Shishido-Hara

  • 1Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan.

Insights

This study details a progressive multifocal leukoencephalopathy (PML) case in a 53-year-old man. Treatment focused on viral suppression and preserving immune response, leading to significant cognitive recovery.

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system caused by the JC virus.
  • PML typically affects immunocompromised individuals and can lead to severe neurological deficits.

Observation:

  • A 53-year-old man presented with sub-acute dementia and Gerstmann syndrome.
  • MRI revealed white matter lesions in the left parietal lobe with peripheral enhancement.
  • Brain biopsy confirmed JC virus infection in oligodendrocytes and a balanced infiltration of CD8+ and CD4+ T lymphocytes.

Findings:

  • The patient was diagnosed with PML with controlled inflammation, indicated by the presence of CD4/CD8 T cells.
  • Treatment involved risperidone, cytarabine, and mefloquine to suppress viral replication, deliberately withholding corticosteroids.
  • This approach aimed to preserve the immune system's involvement in controlling the infection.

Implications:

  • The patient showed significant cognitive recovery, with Mini-Mental State Examination scores improving from 5/30 to 26/30 within a year.
  • This case suggests that preserving immune response by avoiding corticosteroids may be a valuable therapeutic strategy in PML.
  • Further research into immunomodulatory therapies for PML is warranted.